Glaxosmithkline

Pic:getty/manjurul

GSK gets FDA approval for MMR vaccine Priorix

By Rachel Arthur

The US Food and Drug Administration (FDA) has approved GSK’s Priorix (Measles, Mumps and Rubella Vaccine, Live) for individuals 12 months of age and older.

Pic:getty/imagesbytangmingtung

Positive booster data for Sanofi/GSK COVID-19 vaccine

By Rachel Arthur

A single booster dose of Sanofi and GSK’s recombinant adjuvanted COVID-19 vaccine candidate delivered ‘consistently strong immune responses’, according to data released by the companies.

Pic:getty/nezman

GSK to help manufacture Novavax COVID-19 vaccine

By Rachel Arthur

GSK will help manufacture up to 60 million doses of Novavax’s COVID-19 vaccine from its facility at Barnard Castle in the UK, with doses to be distributed in the country.

Pic:getty/alekesejplantanov

Sanofi to help manufacture Janssen COVID-19 vaccine

By Rachel Arthur

Sanofi’s vaccine manufacturing plant in Marcy l’Etoile, France, will formulate and fill vials of Janssen’s COVID-19 vaccine: producing around 12 million doses a month to help address global supply demands.

GSK House in Brentford, UK (source GSK)

update - comment from Unite

GSK says UK manufacturing cuts not Brexit related

By Gareth Macdonald

GSK has announced a shakeup of its UK network, shelving plans for Ulverston biopharma plant, mooting the sale of its cephalosporin antibiotics business and pledging to invest in HIV and respiratory drug capacity.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers